The Leadership Team at PsychoGenics is responsible for strategic decision-making, guiding the company's research and development efforts, and ensuring compliance with regulatory standards. This multidisciplinary group collaborates to drive innovation, optimize operations, and foster partnerships, while overseeing critical areas such as drug discovery, engineering, and client relations to advance PsychoGenics' mission in preclinical testing and research services.
Christina Leahy
VP, QA & Regulatory Affairs
Dani Brunner
Chief Innovation Officer
David Bleakman
President, Drug Discovery & De...
Emer Leahy
President & CEO
Jean-Sebastien Valoi...
VP, Engineering & AI Developme...
Kathleen Kelly
VP, Human Resources
Mark Varney
Chief Scientific Officer
Ronald E.D. Christop...
VP, Finance
Sylvie Ramboz
SVP, Behavioral Pharmacology
Taleen Hanania
EVP, External Client Affairs
View all